Full name
TG PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -44,9 | -199,7 | -159,1 | 20,3 |
Gross profit (loss) | -44,8 | -207,3 | -165,5 | 20,1 |
EBITDA | -44,8 | -199,7 | -157,4 | 21,2 |
Short time liabilities | 78,5 | 287 | 96,6 | -66,3 |
Other operating costs | 0 | 0 | 0 | 116,7 |
Equity capital | -39,8 | -247,1 | -26,2 | 89,4 |
Operating profit (EBIT) | -44,8 | -199,7 | -159,1 | 20,3 |
Assets | 38,7 | 39,9 | 70,5 | 76,6 |
Net profit (loss) | -44,8 | -207,3 | -165,5 | 20,1 |
Cash | 1,7 | 5,8 | 3,3 | -42,3 |
Liabilities and provisions for liabilities | 78,5 | 287 | 96,6 | -66,3 |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 38,7 | 39,9 | 69,7 | 74,7 |
Other income costs | 0,1 | 0 | 0 | 66,7 |
Depreciation | 0 | 0 | 1,7 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 112,6 | 83,9 | 633 | 549,1 |
Equity capital to total assets | -103 | -619,5 | -37,1 | 582,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.4926503598690033 | 0.13899265229701996 | 0.7211275696754456 | 0,6 |
Net dept to EBITDA | -1.6688497066497803 | -1.4035208225250244 | -0.5838472247123718 | 0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane